NGM BIOPHARMACEUTICALS INC: cashflow_investing

Value{"amount": -117156000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Period2021-01-01 – 2021-03-31
Statuscurrent
EntityNGM BIOPHARMACEUTICALS INC
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001628280-21-009327 · Open the official SEC filing →
Retrieved: 2026-08-19T14:00:53.965828+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001426332/cashflow-investing/2021-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/c0e063d3-8308-47dc-8fdd-99b8d9cc194c

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies